siRNA-Mediated Silencing of CIP2A Enhances Docetaxel Activity Against PC-3 Prostate Cancer Cells

por Razi Soofiyani, Saiedeh, Mohammad Hoseini, Akbar, Mohammadi, Ali, Khaze Shahgoli, Vahid, Baradaran, Behzad, Hejazi, Mohammad Saeid
Publicado 2017